PATENT PENDING

Gencay MM, Rüdiger JJ, Roth M. Specific assay reagents for quantitative determination of inactive and active form of the glucocorticoid receptor by a DNA enzyme-linked immunosorbent assay.

RECENT PUBLICATIONS

Hoch M, Eberle AN, Peterli R, Peters T, Seboek D, Keller U, Muller B, Linscheid P. LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-alpha in human adipocytes. Department of Research, University Hospital, CH-4031 Basel, Switzerland; University Children's Hospital, CH-4005 Basel, Switzerland. Cytokine. 2008 Jan;41(1):29-37. Epub 2007 Dec 3

Seidel P, Merfort A , Gencay MM, Hughes JM, Black JL, Tamm M , Roth M. Dimethylfumarate reduces growth factor- and cytokine-induced IL-6 release from human lung fibroblasts: role of NF_B. ASMR National Scientific Conference on Tissue Remodelling: Current Understanding and Future Therapeutic Targets, The Carrington,
Katoomba, Blue Mountains, NSW , 11th - 13th November 2007.

Goulet S, Bihl MP, Gambazzi F, Tamm M, Roth M. Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts. J Cell Physiol. 2007 Jan;210(1):167-76.

Glanville AR, Gencay M, Tamm M, Chhajed P, Plit M, Hopkins P, Abyoun C, Roth M, Malouf M. Chlamydia pneumoniae Infection after lung transplantation. J Heart Lung Transplant. 2005;24:131-136.

Stolz D, Christ-Crain M, Gencay MM, Bingisser R, Huber PR, Muller B, Tamm M. Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection. Swiss Med Wkly. 2006 Jul 8;136(27-28):434-40.

Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004; 363(9409):600-607.

Gencay M and Roth M. C. pneumoniae infections in Asthma. Am J Respir Crit Care Med 2003; 2:31-38.

Gencay MM, Tamm M, Glanville A, Perruchoud AP, Roth M. Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.Infect Immun. 2003;71:5814-5822.

Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol. 2003 Aug;52(Pt 8):721-6.

Sirmatel F, Neyal Muftuoglu M, Tahtaci N, Neyal A, Sirmatel O, Bulbul B. Chlamydia pneumoniae seropositivity in patients with cerebral ischemic attack with or without silent brain infarcts.Ups J Med Sci. 2003;108(3):205-12.

Sirmatel F, Ustunsoy H, Sirmatel O, Akdemir I, Dikensoy O. The relationship between Chlamydia pneumoniae seropositivity and peripheral vascular diseases, acute myocardial infarction and late-onset asthma. Infection. 2003 Oct;31(5):367-8.

Gencay M, Rudiger JJ, Tamm M, Soler M, Perruchoud AP, Roth M. Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma. Am J Respir Crit Care Med 2001: 163:1097-100.

Sirmatel F, Oguz H. Prevalence of Chlamydia trachomatis pooled serotypes BDE and FGK in children with chronic follicular conjunctivitis. Jpn J Ophthalmol. 2000 Sep-Oct;44(5):467-9.

Gencay M, Dereli D, Ertem E, Serter D, Puolakkainen M, Saikku P. Seroprevalence of Chlamydia pneumoniae specific antibodies in different risk groups in Izmir, in Turkey Eur J Epid 1998; 14: 505-5

Gencay M, Koskiniemi M, Saikku P, Puolakkainen M, Raivio K, Koskela P, Vaheri A. Letter. Clin Infect Dis 1996; 23: 208-209.

Koskiniemi M, Gencay M, Salonen O, Puolakkainen M, Färkkilä M, Saikku P, Vaheri A. Chlamydia pneumoniae is associated with central nervous system infections Eur Neurol 1996;36: 160-163.

Gencay M, Koskiniemi M, Saikku P, Puolakkainen M, Raivio K, Koskela P, Vaheri Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis 1995; 21: 424-426.

Gencay M, Eggermann U, Tamm M, Soler M, Perruchoud AP, Glanville A, Roth M, Epitelial cell lung carcinoma is associated with C. pneumoniae infection. (Submitted).